Cost Analysis Model Between The Cobas Braf Test And Sanger Sequencing When Treating Malignant Melanoma Based On The Presence Of V600 Mutations
May 1, 2013, 00:00
10.1016/j.jval.2013.03.651
https://www.valueinhealthjournal.com/article/S1098-3015(13)00722-5/fulltext
Title :
Cost Analysis Model Between The Cobas Braf Test And Sanger Sequencing When Treating Malignant Melanoma Based On The Presence Of V600 Mutations
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00722-5&doi=10.1016/j.jval.2013.03.651
First page :
A134
Section Title :
Cancer
Open access? :
No
Section Order :
201